Health ❯ Healthcare ❯ Chronic Conditions

Obesity Management

Weight Loss Strategies Long-term Care Strategies Behavioral Health BMI and Health Risks Lifestyle Interventions Exercise Recommendations GLP-1 Medications Weight Regain Innovative Treatments Long-term Treatment Solutions Long-term Treatment Long-Term Support Strategies Long-term Treatment Strategies

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Full results are slated for presentation at the American Diabetes Association meeting in June.